Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2016 | 09-2016 | 06-2016 | 12-2015 | |
Operating Expenses | 0 | 383 | 638 | 0 |
Operating Income | N/A | -383 | -638 | N/A |
Interest Expense | 0 | 142 | 133 | 0 |
Other Income | 0 | -19 | 0 | 0 |
Pre-tax Income | 0 | -544 | -771 | 0 |
Net Income Continuous | N/A | -544 | -771 | N/A |
Net Income | $N/A | $-544 | $-771 | $N/A |
EPS Basic Total Ops | N/A | -214.18 | -315.63 | N/A |
EPS Basic Continuous Ops | N/A | -215.24 | -311.96 | N/A |
EPS Diluted Total Ops | N/A | -214.18 | -315.63 | N/A |
EPS Diluted Continuous Ops | N/A | -215.24 | -311.96 | N/A |
EBITDA(a) | $N/A | $-351 | $-638 | $N/A |